BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simoneau-roy J, O’gorman C, Pencharz P, Adeli K, Daneman D, Hamilton J. Insulin sensitivity and secretion in children and adolescents with hypothalamic obesity following treatment for craniopharyngioma. Clinical Endocrinology 2010;72:364-70. [DOI: 10.1111/j.1365-2265.2009.03639.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Jung SY, Lee YJ, Lee HJ, Lee YA, Moon JS, Ko JS, Yang SW, Shin CH. Nonalcoholic fatty liver disease in long-term survivors of childhood-onset craniopharyngioma. Ann Pediatr Endocrinol Metab 2017;22:189-96. [PMID: 29025206 DOI: 10.6065/apem.2017.22.3.189] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
2 O'gorman CS, Simoneau-roy J, Pencharz P, Macfarlane J, Maclusky I, Narang I, Adeli K, Daneman D, Hamilton J. Sleep-Disordered Breathing Is Increased in Obese Adolescents with Craniopharyngioma Compared with Obese Controls. The Journal of Clinical Endocrinology & Metabolism 2010;95:2211-8. [DOI: 10.1210/jc.2009-2003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
3 Cohen M, Guger S, Hamilton J. Long term sequelae of pediatric craniopharyngioma - literature review and 20 years of experience. Front Endocrinol (Lausanne) 2011;2:81. [PMID: 22645511 DOI: 10.3389/fendo.2011.00081] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
4 Iughetti L, Bruzzi P. Obesity and craniopharyngioma. Ital J Pediatr 2011;37:38. [PMID: 21846381 DOI: 10.1186/1824-7288-37-38] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
5 Bretault M, Laroche S, Lacorte JM, Barsamian C, Polak M, Raffin-Sanson ML, Touraine P, Bouillot JL, Czernichow S, Carette C. Postprandial GLP-1 Secretion After Bariatric Surgery in Three Cases of Severe Obesity Related to Craniopharyngiomas. Obes Surg 2016;26:1133-7. [PMID: 26922186 DOI: 10.1007/s11695-015-1977-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
6 Jung D, Seo GH, Kim YM, Choi JH, Yoo HW. Hepatopulmonary syndrome caused by hypothalamic obesity and nonalcoholic fatty liver disease after surgery for craniopharyngioma: a case report. Ann Pediatr Endocrinol Metab 2018;23:51-5. [PMID: 29609450 DOI: 10.6065/apem.2018.23.1.51] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 van Iersel L, Brokke KE, Adan RAH, Bulthuis LCM, van den Akker ELT, van Santen HM. Pathophysiology and Individualized Treatment of Hypothalamic Obesity Following Craniopharyngioma and Other Suprasellar Tumors: A Systematic Review. Endocr Rev 2019;40:193-235. [PMID: 30247642 DOI: 10.1210/er.2018-00017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 8.3] [Reference Citation Analysis]
8 Jung HW, Kim HY, Kim JY, Cheon JE, Kim IO, Kim SK, Shin CH, Yang SW, Lee YA. Cardiac autonomic dysfunction is associated with hypothalamic damage in patients with childhood-onset craniopharyngioma. PLoS One 2021;16:e0246789. [PMID: 33591998 DOI: 10.1371/journal.pone.0246789] [Reference Citation Analysis]
9 Bomer I, Saure C, Caminiti C, Ramos JG, Zuccaro G, Brea M, Bravo M, Maza C. Comparison of energy expenditure, body composition, metabolic disorders, and energy intake between obese children with a history of craniopharyngioma and children with multifactorial obesity. J Pediatr Endocrinol Metab 2015;28:1305-12. [PMID: 26203601 DOI: 10.1515/jpem-2015-0167] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
10 Elowe-gruau E, Beltrand J, Brauner R, Pinto G, Samara-boustani D, Thalassinos C, Busiah K, Laborde K, Boddaert N, Zerah M, Alapetite C, Grill J, Touraine P, Sainte-rose C, Polak M, Puget S. Childhood Craniopharyngioma: Hypothalamus-Sparing Surgery Decreases the Risk of Obesity. The Journal of Clinical Endocrinology & Metabolism 2013;98:2376-82. [DOI: 10.1210/jc.2012-3928] [Cited by in Crossref: 105] [Cited by in F6Publishing: 89] [Article Influence: 11.7] [Reference Citation Analysis]
11 Cohen M, Syme C, Mccrindle BW, Hamilton J. Autonomic nervous system balance in children and adolescents with craniopharyngioma and hypothalamic obesity. European Journal of Endocrinology 2013;168:845-52. [DOI: 10.1530/eje-12-1082] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
12 Nogueira MC, Berbel Júnior AS, Koenigkam-Santos M, Moreira AC, Nonino CB, de Castro M. Nutritional and endocrinologic evaluation of patients with craniopharyngioma. Clin Nutr ESPEN 2015;10:e213-8. [PMID: 28531465 DOI: 10.1016/j.clnesp.2015.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
13 Roth CL, Aylward E, Liang O, Kleinhans NM, Pauley G, Schur EA. Functional neuroimaging in craniopharyngioma: a useful tool to better understand hypothalamic obesity? Obes Facts 2012;5:243-53. [PMID: 22647305 DOI: 10.1159/000338695] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
14 Vasyukova OV, Okorokov PL, Kasyanova YV, Bezlepkina OB. [Energy exchange: how we can personalize obesity therapy]. Probl Endokrinol (Mosk) 2021;67:4-10. [PMID: 34766484 DOI: 10.14341/probl12830] [Reference Citation Analysis]
15 Roemmler-Zehrer J, Geigenberger V, Störmann S, Losa M, Crippa V, Otto B, Bidlingmaier M, Dimopoulou C, Stalla GK, Schopohl J. Food intake regulating hormones in adult craniopharyngioma patients. Eur J Endocrinol 2014;170:627-35. [PMID: 24474740 DOI: 10.1530/EJE-13-0832] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
16 Okorokov PL, Kalinin AL, Strebkova NA, Kareva MA, Vasyukova OV, Peterkova VA, Bezlepkina OB. Comparative assessment of energy metabolism, body composition and metabolic features in children with hypothalamic and simple obesity. Obes metabol 2020;17:249-56. [DOI: 10.14341/omet12552] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Lustig RH. Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment. Front Endocrinol (Lausanne) 2011;2:60. [PMID: 22654817 DOI: 10.3389/fendo.2011.00060] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 5.0] [Reference Citation Analysis]
18 Zhang XY, Yuan K, Fang YL, Wang CL. Growth hormone ameliorates hepatopulmonary syndrome and nonalcoholic steatohepatitis secondary to hypopituitarism in a child: A case report. World J Clin Cases 2022; 10(18): 6211-6217 [DOI: 10.12998/wjcc.v10.i18.6211] [Reference Citation Analysis]
19 Lamas Oliveira C. Metabolic consequences of craniopharyingioma and their management. Endocrinol Nutr 2013;60:529-34. [PMID: 23538279 DOI: 10.1016/j.endonu.2012.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
20 Van Schaik J, Burghard M, Lequin MH, van Maren EA, van Dijk AM, Takken T, Rehorst-Kleinlugtenbelt LB, Bakker B, Meijer L, Hoving EW, Fiocco M, Schouten-van Meeteren AYN, Tissing WJE, van Santen HM. Resting energy expenditure in children at risk of hypothalamic dysfunction. Endocr Connect 2022;11:e220276. [PMID: 35904233 DOI: 10.1530/EC-22-0276] [Reference Citation Analysis]
21 Roth CL, D'Ambrosio G, Elfers C. Activation of nuclear factor kappa B pathway and reduction of hypothalamic oxytocin following hypothalamic lesions. J Syst Integr Neurosci 2016;2:79-84. [PMID: 27512604 DOI: 10.15761/JSIN.1000114] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 O'gorman CS, Syme C, Lang J, Bradley TJ, Wells GD, Hamilton JK. An evaluation of early cardiometabolic risk factors in children and adolescents with Turner syndrome. Clin Endocrinol 2013;78:907-13. [DOI: 10.1111/cen.12079] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
23 Duan D, Wehbeh L, Mukherjee D, Hamrahian AH, Rodriguez FJ, Gujar S, Khalafallah AM, Hage C, Caturegli P, Gallia GL, Ahima RS, Maruthur NM, Salvatori R. Preoperative BMI Predicts Postoperative Weight Gain in Adult-onset Craniopharyngioma. J Clin Endocrinol Metab 2021;106:e1603-17. [PMID: 33417676 DOI: 10.1210/clinem/dgaa985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Thompson CJ, Costello RW, Crowley RK. Management of hypothalamic disease in patients with craniopharyngioma. Clin Endocrinol (Oxf) 2019;90:506-16. [PMID: 30614015 DOI: 10.1111/cen.13929] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
25 Chai-Udom R, Aroonparkmongkol S, Sahakitrungruang T. Metabolic features and changes in glucose-induced serum glucagon-like peptide-1 levels in children with hypothalamic obesity. J Pediatr Endocrinol Metab 2020;33:331-7. [PMID: 29389666 DOI: 10.1515/jpem-2017-0350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Yosef L, Ekkehard KM, Shalom M. Giant craniopharyngiomas in children: short- and long-term implications. Childs Nerv Syst 2016;32:79-88. [DOI: 10.1007/s00381-015-2961-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
27 Roth CL, Perez FA, Whitlock KB, Elfers C, Yanovski JA, Shoemaker AH, Abuzzahab MJ. A phase 3 randomized clinical trial using a once-weekly glucagon-like peptide-1 receptor agonist in adolescents and young adults with hypothalamic obesity. Diabetes Obes Metab 2021;23:363-73. [PMID: 33026160 DOI: 10.1111/dom.14224] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Haliloglu B, Bereket A. Hypothalamic obesity in children: pathophysiology to clinical management. J Pediatr Endocrinol Metab 2015;28:503-13. [PMID: 25781673 DOI: 10.1515/jpem-2014-0512] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
29 . Current world literature. Curr Opin Endocrinol Diabetes Obes 2011;18:83-98. [PMID: 21178692 DOI: 10.1097/MED.0b013e3283432fa7] [Reference Citation Analysis]
30 Sahakitrungruang T, Klomchan T, Supornsilchai V, Wacharasindhu S. Obesity, metabolic syndrome, and insulin dynamics in children after craniopharyngioma surgery. Eur J Pediatr 2011;170:763-9. [DOI: 10.1007/s00431-010-1347-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
31 Roth CL. Hypothalamic Obesity in Craniopharyngioma Patients: Disturbed Energy Homeostasis Related to Extent of Hypothalamic Damage and Its Implication for Obesity Intervention. J Clin Med 2015;4:1774-97. [PMID: 26371051 DOI: 10.3390/jcm4091774] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
32 Hamilton JK, Conwell LS, Syme C, Ahmet A, Jeffery A, Daneman D. Hypothalamic Obesity following Craniopharyngioma Surgery: Results of a Pilot Trial of Combined Diazoxide and Metformin Therapy. Int J Pediatr Endocrinol 2011;2011:417949. [PMID: 21603206 DOI: 10.1155/2011/417949] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 4.7] [Reference Citation Analysis]
33 Li X, Wu W, Miao Q, He M, Zhang S, Zhang Z, Lu B, Yang Y, Shou X, Li Y, Wang Y, Ye H. Endocrine and Metabolic Outcomes After Transcranial and Endoscopic Endonasal Approaches for Primary Resection of Craniopharyngiomas. World Neurosurg 2019;121:e8-e14. [PMID: 30266691 DOI: 10.1016/j.wneu.2018.08.092] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
34 Lloret-Linares C, Faucher P, Coupaye M, Alili R, Green A, Basdevant A, Clément K, Poitou C. Comparison of body composition, basal metabolic rate and metabolic outcomes of adults with Prader Willi syndrome or lesional hypothalamic disease, with primary obesity. Int J Obes (Lond) 2013;37:1198-203. [PMID: 23318724 DOI: 10.1038/ijo.2012.228] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
35 Kalina MA, Wilczek M, Kalina-Faska B, Skała-Zamorowska E, Mandera M, Małecka Tendera E. Carbohydrate-lipid profile and use of metformin with micronized fenofibrate in reducing metabolic consequences of craniopharyngioma treatment in children: single institution experience. J Pediatr Endocrinol Metab 2015;28:45-51. [PMID: 25536662 DOI: 10.1515/jpem-2014-0425] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
36 Wijnen M, Olsson DS, van den Heuvel-Eibrink MM, Hammarstrand C, Janssen JAMJL, van der Lely AJ, Johannsson G, Neggers SJCMM. The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up. Eur J Endocrinol 2018;178:11-22. [PMID: 28882980 DOI: 10.1530/EJE-17-0387] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 3.6] [Reference Citation Analysis]